Cargando…

eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients

Antibody-dependent cell-mediated cytotoxity (ADCC) can eliminate HIV-1 infected cells, and may help reduce the reservoir of latent virus in infected patients. Sera of HIV-1 positive individuals include a number of antibodies that recognize epitopes usually occluded on HIV-1 envelope glycoprotein (En...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis-Gardner, Meredith E., Gardner, Matthew R., Alfant, Barnett, Farzan, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749896/ https://www.ncbi.nlm.nih.gov/pubmed/29253851 http://dx.doi.org/10.1371/journal.ppat.1006786

Ejemplares similares

Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission
por: Goyal, Ashish, et al.
Publicado: (2022)

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies
por: Davis-Gardner, Meredith E., et al.
Publicado: (2020)

HIV-1 inhibitory properties of eCD4-Igmim2 determined using an Env-mediated membrane fusion assay
por: Yang, Edward, et al.
Publicado: (2018)

A lentiviral vector B cell gene therapy platform for the delivery of the anti-HIV-1 eCD4-Ig-knob-in-hole-reversed immunoadhesin
por: Vamva, Eirini, et al.
Publicado: (2023)

AAV-expressed eCD4-Ig provides durable protection from multiple SHIV challenges
por: Gardner, Matthew R., et al.
Publicado: (2015)

Synthetic DNA delivery by electroporation promotes robust in vivo sulfation of broadly neutralizing anti-HIV immunoadhesin eCD4-Ig
por: Xu, Ziyang, et al.
Publicado: (2018)

Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies
por: Otsuka, Yuka, et al.
Publicado: (2018)

Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies
por: Gardner, Matthew R., et al.
Publicado: (2019)

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies
por: Parsons, Matthew S., et al.
Publicado: (2015)

1833. Measuring Influenza HA Stem-Specific ADCC in Human Sera Using Novel Stabilized Stem Nanoparticle Probes
por: Smatti, Maria K, et al.
Publicado: (2019)

Piperidine CD4-mimetic compounds expose vulnerable Env epitopes sensitizing HIV-1-infected cells to ADCC
por: Ding, Shilei, et al.
Publicado: (2023)

Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC
por: Ding, Shilei, et al.
Publicado: (2023)

γδT cells are ADCC effectors in elite HIV controllers
por: Poonia, Bhawna, et al.
Publicado: (2010)

FcγR Binding and ADCC Activity of Human IgG Allotypes
por: de Taeye, Steven W., et al.
Publicado: (2020)

Examination of IgG Fc Receptor CD16A and CD64 Expression by Canine Leukocytes and Their ADCC Activity in Engineered NK Cells
por: Hullsiek, Robert, et al.
Publicado: (2022)

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
por: Aziz, Mariam, et al.
Publicado: (2015)

Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site
por: Bogers, Willy M. J. M., et al.
Publicado: (2017)

In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
por: Thomann, Marco, et al.
Publicado: (2015)

Can HIV-1-Specific ADCC Assist the Clearance of Reactivated Latently Infected Cells?
por: Lee, Wen Shi, et al.
Publicado: (2015)

Engineering antibody-like inhibitors to prevent and treat HIV-1 infection
por: Gardner, Matthew R., et al.
Publicado: (2017)

P04-25. Exposure of HIV-1 pseudovirus to soluble CD4 increases the breadth of neutralization with sera from macaques immunized with recombinant glycoproteins
por: Davis, D, et al.
Publicado: (2009)

The Yin and Yang of ADCC-Mediating Antibodies
por: Robert-Guroff, Marjorie
Publicado: (2016)

Direct Determination of ECD in ECD Kit: A Solid Sample Quantitation Method for Active Pharmaceutical Ingredient in Drug Product
por: Chao, Ming-Yu, et al.
Publicado: (2011)

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
por: Suryawanshi, Poonam, et al.
Publicado: (2021)

Ecd promotes U5 snRNP maturation and Prp8 stability
por: Erkelenz, Steffen, et al.
Publicado: (2021)

Men care too: a qualitative study examining women’s perceptions of fathers’ engagement in early childhood development (ECD) during an ECD program for HIV-positive mothers in Malawi
por: Temelkovska, Tijana, et al.
Publicado: (2022)

Measurements of nitrous oxide in the atmosphere via E.C.D. gas chromatography at Harwell
por: Brice, K A, et al.
Publicado: (1977)

Co-receptor Binding Site Antibodies Enable CD4-Mimetics to Expose Conserved Anti-cluster A ADCC Epitopes on HIV-1 Envelope Glycoproteins
por: Richard, Jonathan, et al.
Publicado: (2016)

HIV-Specific Antibodies Capable of ADCC Are Common in Breastmilk and Are Associated with Reduced Risk of Transmission in Women with High Viral Loads
por: Mabuka, Jennifer, et al.
Publicado: (2012)

Development of a Macrophage-Based ADCC Assay
por: Uccellini, Melissa B., et al.
Publicado: (2021)

Decoding the ECD Spectra of Poly(phenylacetylene)s: Structural Significance
por: Fernández, Berta, et al.
Publicado: (2019)

Cross-species higher sensitivities of FcγRIIIA/FcγRIV to afucosylated IgG for enhanced ADCC
por: Mao, Changchuin, et al.
Publicado: (2021)

Improved HIV-positive infant survival is correlated with high levels of HIV-specific ADCC activity in multiple cohorts
por: Yaffe, Zak A., et al.
Publicado: (2021)

Detection of Mannheimia haemolytica-Specific IgG, IgM and IgA in Sera and Their Relationship to Respiratory Disease in Cattle
por: Poonsuk, Korakrit, et al.
Publicado: (2023)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
por: Yaffe, Zak A., et al.
Publicado: (2023)

Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering
por: Roßkopf, Sophia, et al.
Publicado: (2020)

Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52(+) T-cell malignancies
por: Miljkovic, Milos D., et al.
Publicado: (2022)

ECD promotes gastric cancer metastasis by blocking E3 ligase ZFP91-mediated hnRNP F ubiquitination and degradation
por: Xu, Song-Hui, et al.
Publicado: (2018)

PPD-specific IgG and IgG subclasses in the sera of pulmonary tuberculosis patients.
por: Hwang, P. H., et al.
Publicado: (1993)

ADCC potency assay: increased standardization with modified lymphocytes
por: Bretaudeau, Laurent, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_s2q788itlruta5l5hgv7fhp6pg